DarioHealth Corp Buy Hold or Sell Recommendation

DRIO -- USA Stock  

USD 1.04  0.09  9.47%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding DarioHealth Corp is 'Strong Sell'. Macroaxis provides DarioHealth Corp buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DRIO positions. The advice algorithm takes into account all of DarioHealth Corp available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from DRIO buy-and-hold prospective. Additionally see DarioHealth Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell DarioHealth CorpBuy DarioHealth Corp
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon DarioHealth Corp has a mean deviation of 3.04, semi deviation of 0.0, standard deviation of 4.88, variance of 23.82, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on DarioHealth Corp. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure DarioHealth Corp is not overpriced, please confirm all DarioHealth Corp fundamentals including its Price to Sales, Cash Flow from Operations, Current Liabilities, as well as the relationship between Cash and Equivalents and Market Capitalization . Given that DarioHealth Corp is a hitting penny stock territory we advise to closely look at its Number of Shares Shorted.

DarioHealth Corp Thematic Classifications

Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

DarioHealth Corp Returns Distribution Density

Mean Return0.29Value At Risk10.51
Potential Upside7.61Standard Deviation4.88
 Return Density 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares107.3 K137 K
Bard Associates IncCommon Shares84.8 K109 K
Virtu Financial LlcCommon Shares26.3 K34 K
Susquehanna International Group LlpCommon Shares22.5 K29 K
Blackrock IncCommon Shares21 K27 K
Citadel Advisors LlcCommon Shares18.9 K24 K
Marco Investment Management LlcCommon Shares15 K19 K
Bard Associates IncWarrants67.4 K8 K

DarioHealth Corp Greeks

Alpha over DOW
Beta against DOW=1.38
Overall volatility
Information ratio =0.1

DarioHealth Corp Volatility Alert

DarioHealth Corp exhibits very low volatility with skewness of -0.62 and kurtosis of 1.08. However, we advise investors to further study DarioHealth Corp technical indicators to make sure all market info is available and is reliable. DarioHealth Corp is a potential penny stock. Although DarioHealth Corp may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in DarioHealth Corp. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare DarioHealth Corp to competition

DarioHealth Corp Fundamental Vs Peers

FundamentalsDarioHealth CorpPeer Average
Return On Equity(249.89) % (15.17) %
Return On Asset(103.78) % (15.64) %
Profit Margin(223.84) % (5.50) %
Operating Margin(221.13) % (10.91) %
Current Valuation14.71 M152.14 B
Shares Outstanding19.78 M1.43 B
Shares Owned by Insiders44.59 % 6.91 %
Shares Owned by Institutions1.30 % 18.37 %
Number of Shares Shorted139.97 K3.24 M
Price to Earning2.30 times40.69 times
Price to Book2.80 times14.44 times
Price to Sales4.18 times17.81 times
Revenue5.92 M9.85 B
Gross Profit1.31 M21.75 B
EBITDA(12.88 M)1.41 B
Net Income(13.5 M)517.71 M
Cash and Equivalents7.23 M3.89 B
Cash per Share0.43 times5.17 times
Debt to Equity(4.21) % 0.72 %
Current Ratio3.70 times3.30 times
Book Value Per Share0.45 times13.64 times
Cash Flow from Operations(10.3 M)1.25 B
Short Ratio2.01 times2.09 times
Earnings Per Share1.17 times2.30 times
Number of Employees4510.67 K
Market Capitalization24.73 M29.78 B
Total Asset5.08 M126.86 B
Retained Earnings(43.35 M)38.24 B
Working Capital2.6 M3.58 B
Current Asset4.29 M36.8 B
Current Liabilities1.69 M33.34 B
Z Score-16.8708.73
   Acquisition by Erez Raphael of 49942 shares of DarioHealth Corp subject to Rule 16b-3 [view details]

DarioHealth Corp Alerts

Trading Alerts and Improvement Suggestions

DarioHealth Corp generates negative expected return over the last 30 days
DarioHealth Corp has high historical volatility and very poor performance
DarioHealth Corp has some characteristics of a very speculative penny stock
DarioHealth Corp has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 5.92 M. Net Loss for the year was (13.5 M) with profit before overhead, payroll, taxes, and interest of 1.31 M.
LABSTYLE currently holds about 7.23 M in cash with (10.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43.
Roughly 45.0% of the company shares are held by company insiders
Latest headline from simplywall.st: DarioHealth Corp exotic insider transaction detected
Additionally see DarioHealth Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Search macroaxis.com